Get the Stockscreener App
0.442
4.99%
+0.021
After Hours:
.442
NeuBase Therapeutics Inc Stock (NBSE) Forecast
The NeuBase Therapeutics Inc (NBSE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.7008, representing a +511.04% increase from the current price of $0.442. The highest analyst price target is $3.8431, and the lowest is $1.5586.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NBSE Price Target
Average 5.14
(+1,063% Upside)
Is NeuBase Therapeutics Inc (NBSE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.59 | Neutral |
| STOCH(9,6) | 48.48 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0753 | Buy |
| ADX(14) | 29.24 | Sell |
| William %R | -30.94 | Neutral |
| CCI(14) | 135.38 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4245
Buy
|
0.4319
Buy
|
| MA20 |
0.4227
Buy
|
0.481
Sell
|
| MA50 |
0.6836
Sell
|
0.5992
Sell
|
| MA100 |
0.6971
Sell
|
0.6747
Sell
|
| MA200 |
0.8333
Sell
|
0.673
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, NBSE could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 9 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on NBSE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.59 indicates that NBSE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.48 indicates that NBSE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that NBSE is oversold. This suggests that NBSE price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.24 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 135.38 indicates that NBSE is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term NBSE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about NeuBase Therapeutics Inc financial reports and earnings history, NeuBase Therapeutics Inc (NBSE) stock could reach $5.9227 by 2030, $3.5867 by 2040 and $9.4901 by 2050. See the projected annual prices until 2050 of the NeuBase Therapeutics Inc stock below:
- NeuBase Therapeutics Inc (NBSE) is expected to reach an average price of $0.9185 in 2035, with a high prediction of $2.994 and a low estimate of $0.0715. This indicates an $107.81% rise from the last recorded price of $0.442.
- NeuBase Therapeutics Inc (NBSE) stock is projected to chart a bullish course in 2040, with an average price target of $0.7847, representing an $77.52% surge from its current level. The forecast ranges from a conservative $3.3647 to a sky-high $3.5867.
- Our analysts predict NeuBase Therapeutics Inc (NBSE) to jump 1,316% by 2045, soaring from $7.0802 to an average price of $6.2609, potentially reaching $6.5384. While $7.0802 is the low estimate, the potential upside is significant.
- NeuBase Therapeutics Inc (NBSE) stock is expected to climb by 2050, reaching an average of $9.9401, a $2,149% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.4901 and $10.03, respectively, highlighting the market's uncertainty.
NeuBase Therapeutics Inc Stock (NBSE) Year by Year Forecast
NeuBase Therapeutics Inc Stock (NBSE) Price Forecast for 2024
Our forecast for NBSE stock price in 2024 now indicates an average price target of $3.4112 with a high forecast of $6.6438 and a low forecast of $0.1786. The average prediction reflects an increase of +671.76% from the last recorded price of $0.442.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $3.6631 | $1.5586 | $3.8431 | +728.75% |
| June, 2024 | $3.9891 | $3.1646 | $5.0376 | +802.51% |
| July, 2024 | $3.6467 | $2.9651 | $4.3321 | +725.03% |
| August, 2024 | $4.3827 | $2.3297 | $4.5215 | +891.56% |
| September, 2024 | $3.4502 | $1.4287 | $5.3257 | +680.59% |
| October, 2024 | $5.1863 | $3.0432 | $5.8062 | +1,073% |
| November, 2024 | $5.7423 | $4.0493 | $5.8523 | +1,199% |
| December, 2024 | $5.4998 | $4.3698 | $6.6438 | +1,144% |
NeuBase Therapeutics Inc Stock (NBSE) Price Forecast for 2025
NeuBase Therapeutics Inc Stock (NBSE) is expected to reach an average price of $6.4884 in 2025, with a high prediction of $10.40 and a low estimate of $2.5783. This indicates an +1,368% rise from the last recorded price of $0.442.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.7659 | $5.0759 | $8.8513 | +1,204% |
| February, 2025 | $4.5869 | $4.2419 | $6.2474 | +937.76% |
| March, 2025 | $5.2394 | $4.6034 | $6.1064 | +1,085% |
| April, 2025 | $4.8555 | $4.3609 | $7.014 | +998.52% |
| May, 2025 | $6.1215 | $4.4881 | $6.7815 | +1,285% |
| June, 2025 | $5.669 | $4.776 | $6.583 | +1,183% |
| July, 2025 | $5.0701 | $4.8821 | $5.7936 | +1,047% |
| August, 2025 | $5.2111 | $4.1996 | $7.1666 | +1,079% |
| September, 2025 | $9.1986 | $4.3941 | $10.40 | +1,981% |
| October, 2025 | $6.7447 | $5.8332 | $9.6402 | +1,426% |
| November, 2025 | $4.9207 | $4.3892 | $6.9862 | +1,013% |
| December, 2025 | $2.9283 | $2.5783 | $5.0722 | +562.50% |
NeuBase Therapeutics Inc Stock (NBSE) Price Forecast for 2026
The predicted value for NeuBase Therapeutics Inc (NBSE) in 2026 is set at an average of $1.6218. Estimates vary from a peak of $3.2258 to a trough of $0.0179, indicating an +266.93% surge from the present price of $0.442.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.9943 | $2.1758 | $3.1928 | +577.44% |
| February, 2026 | $2.5403 | $2.2573 | $3.2258 | +474.73% |
| March, 2026 | $1.3279 | $1.1579 | $2.6118 | +200.42% |
| April, 2026 | $1.6839 | $1.1024 | $1.9539 | +280.97% |
| May, 2026 | $1.8199 | $1.4354 | $1.9769 | +311.75% |
| June, 2026 | $1.8975 | $1.321 | $2.0575 | +329.29% |
| July, 2026 | $1.4535 | $1.4035 | $2.369 | +228.84% |
| August, 2026 | $0.971 | $0.6411 | $1.655 | +119.69% |
| September, 2026 | $0.6871 | $0.4871 | $1.2871 | +55.44% |
| October, 2026 | $0.3269 | $0.0586 | $0.9386 | -26.04% |
| November, 2026 | $0.3094 | $0.3794 | $0.3709 | -30.01% |
| December, 2026 | $0.2617 | $0.0179 | $0.3095 | -40.80% |
NeuBase Therapeutics Inc Stock (NBSE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for NeuBase Therapeutics Inc (NBSE) is $0.5141, with a high forecast of $1.0195 and a low forecast of $0.0088. This indicates an +16.32% increase from the last price of $0.442.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0673 | $0.0088 | $0.3482 | -84.77% |
| February, 2027 | $0.6989 | $0.2858 | $0.5713 | +58.11% |
| March, 2027 | $0.5737 | $0.6067 | $0.5882 | +29.80% |
| April, 2027 | $0.5377 | $0.5615 | $0.5907 | +21.65% |
| May, 2027 | $0.2002 | $0.4252 | $0.4547 | -54.72% |
| June, 2027 | $0.8385 | $0.3836 | $0.669 | +89.71% |
| July, 2027 | $0.9881 | $0.8326 | $0.8585 | +123.55% |
| August, 2027 | $1.0605 | $1.0066 | $1.0077 | +139.94% |
| September, 2027 | $1.0555 | $1.0515 | $1.0175 | +138.80% |
| October, 2027 | $1.0635 | $1.0399 | $1.0123 | +140.61% |
| November, 2027 | $0.9315 | $0.9809 | $1.0195 | +110.76% |
| December, 2027 | $0.9029 | $0.9349 | $0.9078 | +104.28% |
NeuBase Therapeutics Inc Stock (NBSE) Price Forecast for 2028
In 2028, NeuBase Therapeutics Inc (NBSE) is projected to reach an average price of $1.7706, with a high projection of $3.5368 and a low estimate of $0.00447. This indicates an +300.59% rise from the last price of $0.442.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.8788 | $0.8699 | $0.8574 | +98.82% |
| February, 2028 | $0.8563 | $0.8703 | $0.8559 | +93.74% |
| March, 2028 | $0.8603 | $0.8583 | $0.8448 | +94.64% |
| April, 2028 | $0.7726 | $0.7858 | $0.7788 | +74.79% |
| May, 2028 | $1.5983 | $0.7491 | $3.5368 | +261.60% |
| June, 2028 | $0.9043 | $0.8113 | $1.7097 | +104.59% |
| July, 2028 | $0.1272 | $0.00917 | $0.9925 | -71.23% |
| August, 2028 | $0.8279 | $0.0441 | $2.4179 | +87.30% |
| September, 2028 | $0.1019 | $0.00971 | $1.0794 | -76.94% |
| October, 2028 | $0.0514 | $0.024 | $0.1242 | -88.36% |
| November, 2028 | $0.3939 | $0.00447 | $0.9175 | -10.89% |
| December, 2028 | $0.292 | $0.0435 | $0.5405 | -33.94% |
NeuBase Therapeutics Inc Stock (NBSE) Price Forecast for 2029
The 2029 price forecast for NeuBase Therapeutics Inc Stock (NBSE) is $1.8402 on average, with a high prediction of $3.6576 and a low estimate of $0.0228. This represents an +316.33% increase from the previous price of $0.442.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.5881 | $2.1081 | $2.7472 | +259.31% |
| February, 2029 | $1.0461 | $2.2061 | $1.9691 | +136.67% |
| March, 2029 | $1.8255 | $1.36 | $1.574 | +313.01% |
| April, 2029 | $1.7389 | $2.041 | $1.7309 | +293.42% |
| May, 2029 | $0.1969 | $1.6569 | $1.3129 | -55.46% |
| June, 2029 | $1.1352 | $0.0228 | $1.7752 | +156.83% |
| July, 2029 | $0.3303 | $0.0443 | $1.3182 | -25.27% |
| August, 2029 | $0.3524 | $0.1133 | $0.7077 | -20.28% |
| September, 2029 | $0.6156 | $0.0246 | $2.2014 | +39.27% |
| October, 2029 | $2.0295 | $0.0235 | $2.1095 | +359.16% |
| November, 2029 | $1.6516 | $1.0285 | $2.7624 | +273.66% |
| December, 2029 | $1.8666 | $1.6046 | $3.6576 | +322.32% |
NeuBase Therapeutics Inc Stock (NBSE) Price Forecast for 2030
NeuBase Therapeutics Inc Stock (NBSE) is expected to reach an average price of $4.2989 in 2030, with a high forecast of $7.9073 and a low forecast of $0.6905. This signifies an +872.60% surge from the last price of $0.442.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.9487 | $1.4297 | $5.9227 | +567.13% |
| February, 2030 | $1.7408 | $1.7008 | $3.3647 | +293.84% |
| March, 2030 | $2.8928 | $1.3938 | $3.2928 | +554.49% |
| April, 2030 | $3.1679 | $1.5819 | $4.2579 | +616.72% |
| May, 2030 | $2.98 | $1.7666 | $3.3909 | +574.20% |
| June, 2030 | $2.512 | $2.112 | $4.083 | +468.34% |
| July, 2030 | $3.0971 | $2.2641 | $3.2651 | +600.71% |
| August, 2030 | $1.8892 | $1.6392 | $4.5832 | +327.42% |
| September, 2030 | $5.7843 | $1.7922 | $6.4943 | +1,209% |
| October, 2030 | $3.9063 | $3.3763 | $7.9073 | +783.79% |
| November, 2030 | $2.5684 | $1.9784 | $4.7994 | +481.09% |
| December, 2030 | $1.3235 | $0.6905 | $2.8714 | +199.43% |
3.08%
9.90%
Cap:
|
Volume (24h):